Mk-5618
Drug Oncology
General payments
$6,538
Research payments
$2,112,585
Through program year 2020, $6,538 in general payments and $2,112,585 in research payments were reported against Mk-5618 (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $6,538 | 1 |
| 2020 | Research | $1,186,149 | 129 |
| 2019 | Research | $926,436 | 114 |
Breakdown
Each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
1 general · 243 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.